Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infection

Nature Communications

Volumn 10, Issue 1, 2019, Pages

  Tang, Benjamin M ^a,b,c   Shojaei, Maryam ^a,b   Teoh, Sally ^a   Meyers, Adrienne ^d   Ho, John ^d   Ball, T Blake ^d   Keynan, Yoav ^d   Pisipati, Amarnath ^e   Kumar, Aseem ^f   Eisen, Damon P ^g   Lai, Kevin ^h   Gillett, Mark ⁱ   Santram, Rahul ^j   Geffers, Robert ^k   Schreiber, Jens ^l   Mozhui, Khyobeni ^m   Huang, Stephen ^a   Parnell, Grant P ^b   Nalos, Marek ^a,n   Holubova, Monika ⁿ   Chew, Tracy ^o   Booth, David ^b   Kumar, Anand ^d   McLean, Anthony ^a   Schughart, Klaus ^k,m,p   more..

^a NEPEAN HOSPITAL   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c University of Sydney   (Australia)

^d UNIVERSITY OF MANITOBA   (Canada)

^e HARVARD UNIVERSITY   (United States)

^f LAURENTIAN UNIVERSITY   (Canada)

^g TOWNSVILLE HOSPITAL   (Australia)

^h WESTMEAD HOSPITAL   (Australia)

ⁱ ROYAL NORTH SHORE HOSPITAL   (Australia)

^j ST VINCENT S HOSPITAL   (Australia)

^k HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^l OTTO VON GUERICKE UNIVERSITY   (Germany)

^m UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

ⁿ CHARLES UNIVERSITY   (Czech Republic)

^o UNIVERSITY OF SYDNEY   (Australia)

^p UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HOST FACTOR;

DISEASE SEVERITY; DISEASE TREATMENT; INFECTIOUS DISEASE; INFLUENZA; OXYGENATION; PUBLIC HEALTH; STRATIFICATION;

ADULT; APOPTOSIS; ARTICLE; ARTIFICIAL VENTILATION; BLOOD SAMPLING; CELL FRACTIONATION; CHLAMYDIA PNEUMONIAE; DISEASE SEVERITY; DOWN REGULATION; FATALITY; FEMALE; GENE EXPRESSION; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; INFLAMMATION; INFLUENZA; INFLUENZA A; INFLUENZA B; INTENSIVE CARE UNIT; LEGIONELLA PNEUMOPHILA; LENGTH OF STAY; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MYCOPLASMA PNEUMONIAE; NEUTROPHIL; OUTCOME ASSESSMENT; PHENOTYPE; POLYMERASE CHAIN REACTION; PRINCIPAL COMPONENT ANALYSIS; PROGNOSIS; PROSPECTIVE STUDY; RESPIRATORY FAILURE; RISK FACTOR; RNA EXTRACTION; SPUTUM; URINALYSIS; CELL CYCLE; EXTRACELLULAR TRAP; GENETICS; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA B VIRUS; ISOLATION AND PURIFICATION; LUNG; MIDDLE AGED; MORTALITY; PATHOLOGY; VIROLOGY;

ANIMALIA;

CELL CYCLE; EXTRACELLULAR TRAPS; FEMALE; GENE EXPRESSION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA, HUMAN; LUNG; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY;

EID: 85069970756     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-019-11249-y     Document Type: Article

References (45)

1. Hayward, A. C. et al. Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study. Lancet Respir. Med. 2, 445–454 (2014).
2. La Gruta, N. L., Kedzierska, K., Stambas, J. & Doherty, P. C. A question of self-preservation: immunopathology in influenza virus infection. Immunol. Cell Biol. 85, 85–92 (2007).
3. Short, K. R., Kroeze, E. J. B. V., Fouchier, R. A. M. & Kuiken, T. Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect. Dis. 14, 57–69 (2014).
4. Li, C. K. F. et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat. Med. 18, 276–282 (2012).
5. Wang, Z. et al. Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8+ T cells. Nat. Commun. 6, 1–12 (2015). 1AD.
6. Sridhar, S. et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat. Med. 19, 1305–1312 (2013).
7. Kobasa, D., Jones, S. M., Shinya, K., Kash, J. C. & Copps, J. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445, 319–323 (2007).
8. Guo, H. et al. The functional impairment of natural killer cells during influenza virus infection. Immunol. Cell Biol. 87, 579–589 (2009).
9. Herold, S., Becker, C., Ridge, K. M. & Budinger, G. R. S. Influenza virus-induced lung injury: pathogenesis and implications for treatment. Eur. Respir. J. 45, 1463–1478 (2015).
10. de Jong, M. D. et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12, 1203–1207 (2006).
11. PhD, A. D. I. et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 391, 1285–1300 (2018).
12. Zangrillo, A. et al. Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO. Crit. Care 17, R30 (2013).
13. Dobson, J., Whitley, R. J., Pocock, S. & Monto, A. S. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet 385, 1729–1737 (2015).
14. Liu, Q., Zhou, Y.-H. & Yang, Z.-Q. The cytokine storm of severe influenza and development of immunomodulatory therapy. Cell Mol. Immunol. 13, 3–10 (2015).
15. Fedson, D. S. Confronting the next influenza pandemic with anti-inflammatory and immunomodulatory agents: why they are needed and how they might work. Influenza Other Respir. Viruses 3, 129–142 (2009).
16. Gregory, D. J. & Kobzik, L. Influenza lung injury: mechanisms and therapeutic opportunities. Am. J. Physiol. Lung Cell Mol. Physiol. 309, L1041–L1046 (2015).
17. Dimitrakopoulou, K. et al. Influenza A immunomics and public health omics: the dynamic pathway interplay in host response to H1N1 infection. OMICS 18, 167–183 (2014).
18. Pirrone, V., Thakkar, N., Jacobson, J. M., Wigdahl, B. & Krebs, F. C. Combinatorial approaches to the prevention and treatment of HIV-1 infection. Antimicrob. Agents Chemother. 55, 1831–1842 (2011).
19. Zaas, A. K., Chen, M., Varkey, J., Veldman, T. & Hero, A. O. III Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell 6, 207–217 (2009).
20. Zhai, Y. et al. Host transcriptional response to influenza and other acute respiratory viral infections—a prospective cohort study. PLoS Pathog. 11, e1004869–29 (2015).
21. Woods, C. W. et al. A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2. PLoS ONE 8, e52198 (2013).
22. Zhao, W. et al. Weighted gene coexpression network analysis: state of the art. J. Biopharm. Stat. 20, 281–300 (2010).
23. Nedzad Music, A. J. R. J. H. K. I. A. Y. Peripheral Leukocyte Migration in Ferrets in Response to Infection with Seasonal Influenza Virus. 1–17. 10.1371/journal.pone.0157903 (2016).
24. Juss, J. K. et al. Acute respiratory distress syndrome neutrophils have a distinct phenotype and are resistant to phosphoinositide 3-kinase inhibition. Am. J. Respir. Crit. Care Med. 194, 961–973 (2016).
25. Brandes, M., Klauschen, F., Kuchen, S. & Germain, R. N. A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell 154, 197–212 (2013).
26. Teijaro, J. R. The role of cytokine responses during influenza virus pathogenesis and potential therapeutic options. Curr. Top. Microbiol. Immunol. 386, 3–22 (2015).
27. Grimaldi, D., Llitjos, J. F. & Pene, F. Post-infectious immune suppression: a new paradigm of severe infections. Med Mal. Infect. 44, 455–463 (2014).
28. Venet, F., Lepape, A. & Monneret, G. Clinical review: flow cytometry perspectives in the ICU—from diagnosis of infection to monitoring of injury-induced immune dysfunctions. Crit. Care 15, 231 (2011).
29. van Vught, L. A. et al. Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. J. Am. Med. Assoc. 315, 1469–1479 (2016).
30. Jiang, W. et al. Influenza A virus NS1 induces G0/G1 cell cycle arrest by inhibiting the expression and activity of RhoA protein. J. Virol. 87, 3039–3052 (2013).
31. He, Y. et al. Influenza A virus replication induces cell cycle arrest in G0/G1 phase. J. Virol. 84, 12832–12840 (2010).
32. Fan, Y. et al. Cell cycle-independent role of cyclin D3 in host restriction of influenza virus infection. J. Biol. Chem. 292, 5070–5088 (2017).
33. Sun, J., Madan, R., Karp, C. L. & Braciale, T. J. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 15, 277–284 (2009).
34. Narasaraju, T. et al. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am. J. Pathol. 179, 199–210 (2011).
35. Vorobjeva, N. V. & Pinegin, B. V. Neutrophil extracellular traps: mechanisms of formation and role in health and disease. Biochemistry 79, 1286–1296 (2014).
36. Stroncek, D. F. Neutrophil-specific antigen HNA-2a, NB1 glycoprotein, and CD177. Curr. Opin. Hematol. 14, 688–693 (2007).
37. Metz, C. E. Basic principles of ROC analysis. Semin. Nucl. Med. 8, 283–298 (1978).
38. Hufford, M. M. et al. Influenza-infected neutrophils within the infected lungs act as antigen presenting cells for anti-viral CD8(+) T cells. PLoS ONE 7, e46581 (2012).
39. Maetschke, S. R., Madhamshettiwar, P. B., Davis, M. J. & Ragan, M. A. Supervised, semi-supervised and unsupervised inference of gene regulatory networks. Brief Bioinforma. 15, 195–211 (2014).
40. Teluguakula, N. & Harshini, A. Neutrophils as possible therapeutic targets in severe influenza pneumonia. J. Infect. Pulm. Dis. 2, 1 (2016).
41. Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinforma. 9, 559–13 (2008).
42. Parnell, G. P. et al. A distinct influenza infection signature in the blood transcriptome of patients with severe community-acquired pneumonia. Crit. Care 16, R157 (2012).
43. Parnell, G. et al. Aberrant cell cycle and apoptotic changes characterise severe influenza A infection—a meta-analysis of genomic signatures in circulating leukocytes. PLoS ONE 6, e17186 (2011).
44. Van Kerkhove, M. D. et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med. 8, e1001053–12 (2011).
45. BA, K. D. et al. Oxygenation saturation index predicts clinical outcomes in ARDS. Chest 152, 1151–1158 (2017).